Managed Account Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$320M Sell
1,056,013
-11,972
-1% -$3.57M 0.26% 102
2015
Q1
$318M Buy
1,067,985
+206,562
+24% +$58.9M 0.28% 97
2014
Q4
$222M Buy
861,423
+286,372
+50% +$71.6M 0.22% 125
2014
Q3
$139M Buy
575,051
+346,887
+152% +$77.6M 0.15% 168
2014
Q2
$50.9M Sell
228,164
-17,344
-7% -$3.59M 0.06% 360
2014
Q1
$50.5M Buy
245,508
+55,843
+29% +$11.1M 0.07% 339
2013
Q4
$31.9M Buy
189,665
+45,657
+32% +$7.14M 0.04% 460
2013
Q3
$20.7M Sell
144,008
-20,342
-12% -$2.71M 0.03% 604
2013
Q2
$20.7M Buy
+164,350
New +$18.6M 0.03% 555

Other funds holding AGN

Managed Account Advisors's AGN Position: Q2 2015 in Review

Managed Account Advisors reduced its Allergan plc (AGN) stake by 1.1% in Q2 2015, selling an estimated $3.57M and leaving 1,056,013 shares worth $320M. The position accounts for 0.26% of the portfolio, ranked #102.

Managed Account Advisors first reported a position in AGN in Q2 2013 and has held it in 9 quarters since. 1,036 funds tracked by Wall St. Rank hold AGN as of Q2 2015.

  • Managed Account Advisors held 1,056,013 shares of Allergan plc worth $320M as of Q2 2015.
  • Managed Account Advisors sold 11,972 Allergan plc shares in Q2 2015, an estimated $3.57M.
  • Allergan plc made up 0.26% of Managed Account Advisors's portfolio in Q2 2015, its #102 holding.
  • Managed Account Advisors first reported a position in Allergan plc in Q2 2013 and has held it in 9 quarters since.
  • 1,036 funds tracked by Wall St. Rank held Allergan plc as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.